BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 24363251)

  • 1. New iPSC for old long QT syndrome modeling: putting the evidence into perspective.
    Li G; Cheng G; Wu J; Ma S; Sun C
    Exp Biol Med (Maywood); 2014 Feb; 239(2):131-40. PubMed ID: 24363251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling long QT syndromes using induced pluripotent stem cells: current progress and future challenges.
    Friedrichs S; Malan D; Sasse P
    Trends Cardiovasc Med; 2013 May; 23(4):91-8. PubMed ID: 23266156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiomyocytes obtained from induced pluripotent stem cells with long-QT syndrome 3 recapitulate typical disease-specific features in vitro.
    Malan D; Friedrichs S; Fleischmann BK; Sasse P
    Circ Res; 2011 Sep; 109(8):841-7. PubMed ID: 21799153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease characterization using LQTS-specific induced pluripotent stem cells.
    Egashira T; Yuasa S; Suzuki T; Aizawa Y; Yamakawa H; Matsuhashi T; Ohno Y; Tohyama S; Okata S; Seki T; Kuroda Y; Yae K; Hashimoto H; Tanaka T; Hattori F; Sato T; Miyoshi S; Takatsuki S; Murata M; Kurokawa J; Furukawa T; Makita N; Aiba T; Shimizu W; Horie M; Kamiya K; Kodama I; Ogawa S; Fukuda K
    Cardiovasc Res; 2012 Sep; 95(4):419-29. PubMed ID: 22739119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced pluripotent stem cells in cardiovascular research.
    Sinnecker D; Dirschinger RJ; Goedel A; Moretti A; Lipp P; Laugwitz KL
    Rev Physiol Biochem Pharmacol; 2012; 163():1-26. PubMed ID: 22447279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modelling the long QT syndrome with induced pluripotent stem cells.
    Itzhaki I; Maizels L; Huber I; Zwi-Dantsis L; Caspi O; Winterstern A; Feldman O; Gepstein A; Arbel G; Hammerman H; Boulos M; Gepstein L
    Nature; 2011 Mar; 471(7337):225-9. PubMed ID: 21240260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induced pluripotent stem cell-derived cardiomyocytes as models for genetic cardiovascular disorders.
    Josowitz R; Carvajal-Vergara X; Lemischka IR; Gelb BD
    Curr Opin Cardiol; 2011 May; 26(3):223-9. PubMed ID: 21451408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of induced pluripotent stem cell technology.
    Zhou H; Ding S
    Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induced pluripotent stem cell-derived cardiomyocytes: a versatile tool for arrhythmia research.
    Sinnecker D; Goedel A; Laugwitz KL; Moretti A
    Circ Res; 2013 Mar; 112(6):961-8. PubMed ID: 23569105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induced pluripotent stem cells in research and therapy.
    Teoh HK; Cheong SK
    Malays J Pathol; 2012 Jun; 34(1):1-13. PubMed ID: 22870592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. iPS cell technologies and cartilage regeneration.
    Tsumaki N; Okada M; Yamashita A
    Bone; 2015 Jan; 70():48-54. PubMed ID: 25026496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long QT Syndrome: Genetics and Future Perspective.
    Wallace E; Howard L; Liu M; O'Brien T; Ward D; Shen S; Prendiville T
    Pediatr Cardiol; 2019 Oct; 40(7):1419-1430. PubMed ID: 31440766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induced pluripotent stem cell technology: Toward the future of cardiac arrhythmias.
    Gnecchi M; Stefanello M; Mura M
    Int J Cardiol; 2017 Jun; 237():49-52. PubMed ID: 28408106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Precision Medicine Approach to the Rescue of Function on Malignant Calmodulinopathic Long-QT Syndrome.
    Limpitikul WB; Dick IE; Tester DJ; Boczek NJ; Limphong P; Yang W; Choi MH; Babich J; DiSilvestre D; Kanter RJ; Tomaselli GF; Ackerman MJ; Yue DT
    Circ Res; 2017 Jan; 120(1):39-48. PubMed ID: 27765793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [iPS cells for the generation of cartilage and for regenerative medicine and disease modeling of cartilage diseases].
    Tsumaki N
    Clin Calcium; 2016 Apr; 26(4):587-92. PubMed ID: 27013630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An electrifying iPSC disease model: long QT syndrome type 2 and heart cells in a dish.
    Kamp TJ
    Cell Stem Cell; 2011 Feb; 8(2):130-1. PubMed ID: 21295269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular genetics in the hereditary form of long QT syndrome].
    Georgijević Milić L
    Med Pregl; 2000; 53(1-2):51-4. PubMed ID: 10953551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induced pluripotent stem cell-derived cardiomyocytes and long QT syndrome: is personalized medicine ready for prime time?
    Priori SG
    Circ Res; 2011 Sep; 109(8):822-4. PubMed ID: 21960720
    [No Abstract]   [Full Text] [Related]  

  • 19. The Long QT Syndrome.
    Vohra J
    Heart Lung Circ; 2007; 16 Suppl 3():S5-12. PubMed ID: 17627884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Progress in induced pluripotent stem cell research for age-related neurodegenerative diseases].
    Ito D; Yagi T; Suzuki N
    Brain Nerve; 2013 Mar; 65(3):283-8. PubMed ID: 23475520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.